190 related articles for article (PubMed ID: 19764771)
1. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.
Zhang F; Zhang H; Wang Z; Yu M; Tian R; Ji W; Yang Y; Niu R
Biochem Pharmacol; 2014 Jan; 87(2):292-302. PubMed ID: 24239898
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
Chuthapisith S; Layfield R; Kerr ID; Hughes C; Eremin O
Int J Oncol; 2007 Jun; 30(6):1545-51. PubMed ID: 17487377
[TBL] [Abstract][Full Text] [Related]
4. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
5. Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells.
Yang Y; Wu N; Wang Z; Zhang F; Tian R; Ji W; Ren X; Niu R
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754360
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
7. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
8. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Perera CN; Spalding HS; Mohammed SI; Camarillo IG
Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
[TBL] [Abstract][Full Text] [Related]
9. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
10. Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells.
Sun YL; Zhou GY; Li KN; Gao P; Zhang QH; Zhen JH; Bai YH; Zhang XF
Neoplasma; 2006; 53(1):1-8. PubMed ID: 16416005
[TBL] [Abstract][Full Text] [Related]
11. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
[TBL] [Abstract][Full Text] [Related]
12. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.
Mutoh K; Tsukahara S; Mitsuhashi J; Katayama K; Sugimoto Y
Cancer Sci; 2006 Nov; 97(11):1198-204. PubMed ID: 16925584
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
15. Loss of E-cadherin in multidrug resistant breast cancer cell line MCF-7/Adr: possible implication in the enhanced invasive ability.
Lu L; Zhou D; Jiang X; Song K; Li K; Ding W
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1271-9. PubMed ID: 23047512
[TBL] [Abstract][Full Text] [Related]
16. [Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].
Chen J; Yuan YW; Zhang JR; Zhou DY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):124-6. PubMed ID: 12390804
[TBL] [Abstract][Full Text] [Related]
17. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
18. Identification of proteins associated to multi-drug resistance in LoVo human colon cancer cells.
Visentin M; Simula MP; Sartor F; Petrucco A; De Re V; Toffoli G
Int J Oncol; 2009 May; 34(5):1281-9. PubMed ID: 19360340
[TBL] [Abstract][Full Text] [Related]
19. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
Ogretmen B; Safa AR
Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]